Coto de Caza, CA, United States of America

Maher Albitar

This inventor holds 51 USPTO granted patents and 22 published patent applications and 8 EPO patents, primarily in Cancer Genomics. Top assignees: Quest Diagnostics Investments, Inc., The University of Texas System, Quest Diagnostics Incorporated. Active years: 2009-2026.

USPTO Granted Patents = 51 (Patent Applications = 22)

% Patents Active = 68.6

EPO Patents = 8 (Patent Applications = 12)

Average Co-Inventor Count = 2.0

ph-index = 6

Forward Citations = 119(Granted Patents)

Forward Citations (Not Self Cited) = 52(Dec 10, 2025)

Location History:

Cote De Caza, CA (US) (2013)
Sugarland, TX (US) (2010 - 2018)
Coto de Caza, CA (US) (2009 - 2023)

Company Filing History:

39 out of 499

Quest Diagnostics Investments, Inc.

patents

12 out of 5,630

The University of Texas System

patents

1 out of 9

Quest Diagnostics Incorporated

patents

where one patent can have more than one assignee

Years Active: 2009-2026

Loading Chart...

Areas of Expertise:

JAK2 Mutations

EML4-ALK Translocations

BCR-ABL Variants

Hematopoietic Cell Phenotyping

Circulating MicroRNA

Gene Dysregulation

Therapeutic Antibodies

Prostate Disease Diagnosis

Plasma Proteomic Patterns

Myeloproliferative Disease

TCR-Gamma Rearrangement

51 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12699095 - CANCER DIAGNOSIS USING KI-67 (2026-08-04),

2. 12378609 - Compositions and methods for detecting mutations in JAK2 nucleic acid (2025-08-05),

3. 12305241 - EML4-ALK translocations in lung cancer (2025-05-20),

4. 12153049 - BCR-ABL variants (2024-11-26),

5. 11828760 - Hematopoietic cell phenotyping using circulating cell-free markers (2023-11-28),

6. 11639529 - EML4-ALK translocations in lung cancer (2023-05-02),

7. 11421283 - Circulating microRNA as a marker for hepatocellular carcinoma (2022-08-23),

8. 11345964 - BCR-ABL truncation mutations (2022-05-31),

9. 11275088 - BCR-ABL variants (2022-03-15),

10. 11021758 - Methods for detecting gene dysregulation by intragenic differential expression (2021-06-01),

11. 10954569 - Compositions and methods for detecting mutations in JAK2 nucleic acid (2021-03-23),

12. 10782299 - MPL mutations in JAK2 V617F negative patients with myeloproliferative disease (2020-09-22),

13. 10739345 - BCR-ABL variants (2020-08-11),

14. 10501809 - Methods for detecting gene dysregulation by intragenic differential expression (2019-12-10),

15. 10435758 - EML4-ALK translocations in lung cancer (2019-10-08),

Title: The Innovative Journey of Maher Albitar

Introduction: Maher Albitar, a pioneering inventor based in Coto de Caza, CA (US), has made significant contributions to the field of innovations and patents with his groundbreaking work.

Latest Patents: Maher Albitar holds several patents in various industries, showcasing his diverse range of expertise and innovative thinking.

Career Highlights: With a career spanning several decades, Maher Albitar has established himself as a leading figure in the world of inventions. His passion for pushing the boundaries of technology and creating solutions to complex problems has led to the development of numerous groundbreaking inventions.

Collaborations: Throughout his career, Maher Albitar has collaborated with top researchers, scientists, and engineers to bring his inventions to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of his projects.

Conclusion: Maher Albitar's relentless pursuit of innovation and his dedication to creating impactful inventions have solidified his reputation as a visionary inventor in the industry. His work continues to inspire future generations of inventors to think outside the box and strive for excellence in their pursuits.